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In Brief
The formation of activity-induced DNA double strand breaks within promoter regions is required for transcription of a subset of neuronal early-response genes that are crucial for experience-driven synaptic changes associated with learning and memory.
INTRODUCTION
Neurons are endowed with the remarkable ability to sense and process changes in an organism's external environment. The exposure to a new sensory experience, for instance, profoundly alters the morphology and connectivity of neural circuits, and these changes are thought to be instrumental in the formation of long-lasting memories and adaptive responses (Goelet et al., 1986) . The signaling pathways that underlie these experience-dependent changes have been studied extensively and have led to the current orthodoxy that the initiation of new gene transcription programs is crucial for synaptic plasticity.
Neuronal activity-regulated genes are classified into different subgroups based on the latency of their expression following an activity-dependent stimulus. Genes induced in the earliest wave, referred to as early-response genes, are enriched for transcription factors, such as Fos, Npas4, Egr1, and Nr4a1, and their expression occurs independently of de novo protein synthesis (West and Greenberg, 2011) . These transcription factors then govern the expression of late-response genes, such as Bdnf, Homer1, Nrn1, and Rgs2, which are induced with relatively slower kinetics. In this way, early-response genes ultimately regulate various synaptogenic processes, including neurite outgrowth, synapse development and maturation, and the balance between excitatory and inhibitory synapses (West and Greenberg, 2011) .
The defining characteristic of early-response genes is their rapid and robust expression within minutes after stimulation. A number of molecular features that facilitate this rapid response have been described previously. For instance, even in the absence of an activity-dependent stimulus, the Fos promoter is already bound by the RNA polymerase II (RNAPII) complex and by activity-dependent transcription factors, such as CREB and SRF. Furthermore, nucleosomes at the Fos promoter already carry chromatin modifications that are permissive for active transcription, including histone H3 trimethylated at lysine 4 (H3K4me3) (Kim et al., 2010) . Neuronal activity then variously causes the phosphorylation of CREB and the SRF cofactor, ELK1, the recruitment of the histone acetyltransferase, CBP, to the Fos promoter, and CBP and RNAPII recruitment to enhancer elements of activity-regulated genes (West and Greenberg, 2011) . Together, these changes orchestrate the expression of neuronal activity-regulated genes.
Despite these details however, the precise nature of the molecular switch that precludes early-response gene expression under basal conditions, as well as the mechanisms that override this impediment in response to neuronal activity still remain poorly understood. Our findings suggest that the expression of early-response genes is subdued by the imposition of topological constraints and that the rapid resolution of these constraints in response to neuronal activity involves the generation of DNA double strand breaks (DSBs) within their promoters.
RESULTS

Etoposide-Induced DSBs Stimulate the Expression of Early-Response Genes
Our results stemmed from some unexpected observations made while studying the effects of DSB formation in neurons. The accrual of DNA damage has been linked to various neurological disorders, and we previously described the formation of DNA lesions, particularly DNA DSBs, to be an apical neurotoxic event in several mouse models of neurodegeneration (Dobbin et al., 2013; Kim et al., 2008; Madabhushi et al., 2014; Wang et al., 2013) .
With the idea of further characterizing the consequences of DSB formation in neurons, we incubated cultured primary neurons with etoposide for 6 hr and performed gene expression profiling using next-generation RNA-sequencing (RNA-seq). Etoposide is an established inhibitor of topoisomerase II (Topo II) that traps the enzyme in a complex with the cleaved DNA and thereby converts a normal physiological reaction into a potentially toxic DSB. Transcriptomic analysis after etoposide treatment revealed 692 genes that were differentially expressed compared to vehicle-treated controls. Consistent with the expectation that DSBs would interfere with transcription, an overwhelming majority (680 genes) of the differentially expressed genes were downregulated ( Figure 1A and Table S1 ). Remarkably, however, the 12 genes that were upregulated were enriched for neuronal activity-regulated genes and particularly the so-called early-response genes, such as Fos, FosB, and (C) UCSC genome browser snapshots of RNA-seq trace files from etoposide-treated neurons (green) and vehicle-treated controls (black) at various neuronal activity-regulated genes (violet bars). y axis represents signal intensity and the scale is indicated in parentheses.
(D) Cultured primary neurons were treated with either etoposide (5 mM) or vehicle (DMSO) for 20 min, following which RNA was extracted, and the expression of the indicated genes were assessed using qRT-PCR (n = 3, *p < 0.05, **p < 0.01, ***p < 0.001, two-tailed t test).
(E) Cultured primary neurons were pre-incubated with the ATM inhibitor, KU55933 (ATMi), for 30 min following which etoposide treatment was performed as in (D).
(Top) Neurons were immunostained with antibodies against gH2AX following treatment with etoposide either in the presence or absence of ATMi. (Bottom) The expression of early-response genes, Fos and Npas4, were assessed using qRT-PCR (n = 3, *p < 0.05, **p < 0.01, one-way ANOVA).
(F) Cultured primary neurons were incubated with the indicated drugs for 20 min, following which the expression of Fos and Npas4 was assessed using qRT-PCR (n = 3, **p < 0.01, one-way ANOVA).
Npas4-transcription factors that are also rapidly expressed in response to neuronal activity (Figures 1B and 1C) . Based on these observations, we directly assessed the expression of various neuronal activity-regulated genes after etoposide treatment of cultured primary neurons using quantitative real-time PCR (qRT-PCR). Early-response genes, including Fos, FosB, Npas4, and Egr1 were all upregulated within 20 min of treatment with etoposide ( Figure 1D ). However, other activityregulated genes, such as Bdnf and Homer1, showed no such increase in either the RNA-seq or the qRT-PCR experiments ( Figures 1C and 1D) . Thus, etoposide selectively induces a small subset of activity-regulated genes.
We then evaluated whether etoposide-mediated early-response gene expression is a result of the activation of the DNA damage response. Cultured primary neurons pre-incubated with a specific inhibitor (KU55933; ATMi) against ATM (ataxia telangiectasia mutated) caused a marked reduction in DSB signaling, as indicated by a reduction in the intensity of gH2AX, a marker of DSB signaling ( Figure 1E ). However, ATM inhibition had no effect on the etoposide-mediated increase in Fos and Npas4 expression ( Figure 1E ). In addition to this, we tested whether treatment of neurons with other DSBinducing agents also induced the expression of early-response genes. These agents included the radiomimetic drugs, neocarzinostatin (ncs) and bleomycin (bleo), and the PARP inhibitor, Olaparib (PARPi). Interestingly, none of these drugs recapitulated the effects of etoposide on Fos and Npas4 expression ( Figure 1F ). Together, our results unexpectedly revealed that Topo II-mediated DSBs stimulate the expression of early-response genes.
Neuronal Activity Results in the Formation of DNA DSBs Because early-response genes are normally induced in response to stimulation of neuronal activity, we tested whether established paradigms of neuronal stimulation are also associated with DSB production. Brief incubations of cultured primary neurons with potassium chloride (KCl), N-methyl-D-aspartate (NMDA), or bicucullin (bic), all caused a substantial increase in Fos and Npas4 mRNA (Figures S1A and S1B). Interestingly, each of these treatments also caused an increase in the levels of gH2AX, an established marker of DNA DSBs ( Figure S1C ) (Crowe et al., 2006) .
In addition to this, mouse acute hippocampal slices that were either bath-incubated in NMDA solution or subject to theta-burst electrical stimulation also showed increased gH2AX levels compared to untreated controls (Figures S1D and S1E). To understand whether DSBs are also formed following neuronal activity in vivo, we subjected wild-type C57BL/6 mice to a training paradigm for contextual fear conditioning, following which we prepared hippocampal lysates and measured gH2AX levels. Similar to our observations with cultured primary neurons and hippocampal slices, elevated gH2AX levels were detectable in hippocampal lysates within 15 min after exposure to the fear-conditioning paradigm (Figure S1F) . Moreover, DSB formation has also been reported in other neuronal stimulation paradigms (Suberbielle et al., 2013) . Thus, neuronal activity correlates with the formation of DNA DSBs in neurons.
Neuronal Activity-Induced DNA DSBs Form at Specific Locations in the Genome To further understand the relationship between neuronal activity and DSB formation, we next determined the positions of activitydependent DSBs on a genome-wide level. DSB formation results in the rapid phosphorylation of the histone variant, H2AX, at Ser139 in the vicinity of DSB sites (Rogakou et al., 1998) . The identification of chromatin enriched for gH2AX can be exploited to derive the locations of DSBs (Iacovoni et al., 2010; Rodriguez et al., 2012) . We therefore stimulated cultured primary neurons by briefly incubating them with 50 mM NMDA and then performed genome-wide gH2AX ChIP-seq.
For an initial assessment of genome-wide gH2AX ChIP-seq signals, we classified genomic regions into 14 distinct chromatin states associated with regulatory regions (promoters, enhancers, heterochromatin, etc.) based on available ChIP-seq data of chromatin marks, including H3K36me3, H4K20me1, H3K4me1, H3K27ac, H3K4me3, H3K27me3, and H3K9me3 ( Figure S2A ) (Ernst et al., 2011; Gjoneska et al., 2015) . Correlating the positional information of these chromatin marks with raw gH2AX ChIP-seq signals revealed that the observed increase in gH2AX is confined largely to actively transcribed genes and their downstream regions, but not to enhancers, polycomb repressed regions, or heterochromatin ( Figure 2A ).
To further characterize the distribution of enriched gH2AX signals within genomic regions, we performed differential peak calling (Experimental Procedures) and observed that gH2AX enrichment following NMDA treatment occurs primarily within gene bodies compared to distal intergenic regions ( Figure 2B) . Surprisingly, our analysis revealed only 21 regions that were enriched for gH2AX signals in the NMDA-treated samples compared to controls. Twenty of these regions were within genes, whereas one site was detected in intergenic regions ( Figure 2C ). Remarkably, included within these 21 loci were the earlyresponse genes, Fos, FosB, Npas4, Egr1, Nr4a1, and Nr4a3 (Figure 2C) . In addition to the transcription factors categorized as early-response genes, several other transcription factors, Olig2 and Dlx6os1, as well as several non-coding RNAs, including Malat1, AI854517, and C130071C03Rik were also represented among the loci that showed elevated gH2AX ( Figure 2C ). Additionally, the loci identified by differential peak calling also displayed the highest gH2AX intensities in the NMDA-treated samples, but not in vehicle-treated samples (Tables S2 and S3) .
A closer examination of gH2AX distribution at these loci, including at the early-response genes, revealed a peculiar pattern, with gH2AX peaks initiating adjacent to the transcriptional start site (TSS), spreading into the gene body, and terminating downstream of the 3 0 UTR ( Figure 2D and Figure S2B ). In fact, gH2AX peak width was strictly proportional to gene length ( Figure S2C ). The only exception to this scenario was the case of Homer1, in which gH2AX signals only spanned across the annotated short isoform of Homer1 ( Figure S2B ). While the significance of this is presently unclear, it is noteworthy that only the short isoform of Homer1 is regulated by neuronal activity (Sala et al., 2003) . In contrast to these early-response genes, none of the other late response genes, including Bdnf, Rgs2, Nrn1, and Gpr3 showed an increase in gH2AX intensity in their vicinity following NMDA treatment ( Figure 2D and Figure S2B ). Together these results indicate that activity-dependent stimulation of neurons results in the formation of DNA DSBs at very specific locations in the genome, particularly near early-response genes.
Neuronal Activity-Induced DNA DSBs Are Generated by Topoisomerase IIb In an effort to determine the mechanisms that underlie the formation of neuronal activity-induced DSBs, we returned to our original observation that etoposide treatment is specifically able to upregulate the expression of early-response genes ( Figure 1F ). Etoposide introduces DSBs by targeting Topo II (Vos et al., 2011) . Mammalian cells express two distinct isoforms of Topo II, Topo IIa, and Topo IIb. Topo IIa is mainly expressed in dividing cells, whereas Topo IIb is robustly expressed in postmitotic cells, including neurons, and is primarily implicated in transcriptionrelated functions (Austin and Marsh, 1998) . Incidentally, Topo IIb-mediated DSBs were previously shown to be essential for estradiol-stimulated activation of gene expression (Ju et al., 2006) . These observations caused us to focus specifically on Topo IIb.
We began by assessing Topo IIb binding at various regions of the prototypical early-response gene, Fos, under basal (C) Differential peak calling was performed to determine the regions that were enriched for gH2AX following NMDA treatment (Experimental Procedures). This data were then processed using CIRCOS software (Krzywinski et al., 2009 ) to generate the shown circular representation. The outer ring depicts the mouse chromosomes. The blue ring represents a map of gene densities, and the green ring indicates gH2AX signals. Red lines within the green ring represent loci that were enriched for gH2AX relative to controls. Twenty loci were within genes, and these genes are indicated. One locus was within intergenic regions. (D) UCSC genome browser views depicting the disposition of gH2AX signals within various activity-regulated genes under basal conditions (control) and following NMDA treatment. y axis represents intensity and the range is indicated in parentheses.
conditions. Topo IIb ChIP-qPCR indicated negligible binding in the exons of the Fos gene, as well as within the promoters of b-globin and GAPDH ( Figure 3A ). However, Topo IIb binding was significantly enriched within the Fos promoter ( Figure 3A) . Similarly, Topo IIb binding was also enriched within the Npas4 promoter ( Figure 3A ). These results suggest that Topo IIb is bound to the promoters of early-response genes under basal conditions.
The regulatory elements that bind the Fos promoter are well characterized, and additional ChIP experiments revealed that Topo IIb co-occupies the Fos promoter together with ELK1, as well as the lysine deacetylase, HDAC2 (Figure 3B and Figure S3A) . We previously showed that HDAC2 binds to the promoters of several early-response genes and negatively modulates their expression (Guan et al., 2009) . While screening for proteins that could potentially regulate HDAC2 binding to these promoters, we separately discovered that the protein, tyrosyl DNA phosphodiesterase 2 (TDP2), binds HDAC2 and is enriched at several early-response gene promoters, including Fos and Npas4, under basal conditions ( Figure S3B and data not shown). These results are intriguing because Topo II-mediated DSBs involve the formation of a covalent phosphotyrosyl bond between Topo II and the DNA, and TDP2 specializes in processing these intermediates and in the repair of Topo II-mediated DSBs (Cortes Ledesma et al., 2009 ).
To test whether Topo IIb activity could underlie activityinduced DSB formation, we first measured levels of Topo IIb cleavage complexes following NMDA treatment using an immune complex of enzyme (ICE) assay (Nitiss et al., 2012) . As a control, we incubated neurons with etoposide and observed an increase in Topo IIb covalent complexes ( Figure S3C ). Interestingly, NMDA treatment also caused an increase in Topo IIb covalent complexes, indicating that neuronal activity results in Topo IIb-mediated DNA cleavage ( Figure S3C ). To further assess how neuronal activity affects Topo IIb, we immunoprecipitated Topo IIb following NMDA treatment of primary neurons and incubated the precipitated Topo IIb with supercoiled plasmids. Incubation with Topo IIb caused a potent relaxation of supercoiled plasmids in both NMDA-treated and vehicle-treated samples ( Figure 3C ). However, plasmids incubated with Topo IIb from NMDA-treated samples also displayed increased smearing, indicative of fragmented DNA ( Figure 3C ). These results suggest neuronal activity confers Topo IIb with an increased propensity to generate DNA breaks.
We next performed DNA cleavage assays in which we incubated purified, recombinant Topo IIb together with supercoiled plasmids that either contained or lacked the upstream sequences of the Fos gene. As expected, incubation of supercoiled plasmids with Topo IIb caused an increase in relaxed (Form II) DNA ( Figure 3D ). In the presence of etoposide, an increase in linear (Form III) DNA was also detected in plasmids containing Fos upstream sequences. However, the generation of this linear DNA was sharply attenuated when Fos upstream sequences were deleted ( Figure 3D ). Similar results were also observed with plasmids containing Npas4 upstream sequences. Together, these results suggest that Topo IIb preferentially cleaves the promoters of early-response genes.
Based on Topo IIb binding in the promoters of early-response genes, we then speculated that if Topo IIb generates DSBs in these promoters in an activity-dependent manner, that such cleavage should prevent the amplification of these regions using the primers that detect Topo IIb enrichment ( Figure 3E ). Control Topo IIb ChIP experiments following etoposide treatment of cultured primary neurons revealed a significant reduction in amplification by two distinct primer sets that span the Fos promoter ( Figure 3F ). Importantly, Topo IIb ChIP following NMDA treatment also indicated a sharp reduction in the amplification of the Fos promoter regions ( Figures 3F and S3D) . A similar attenuation in PCR amplification was also observed following ELK1 ChIP in NMDA-treated neurons ( Figure 3G ). To determine whether activity-induced DNA cleavage occurs at a specific site within the Fos promoter, we repeated the PCR amplification assays after Topo IIb ChIP using various primer combinations that spanned the originally identified Topo IIb binding region within the Fos promoter. However, each region that showed enriched amplification following Topo IIb ChIP under basal conditions also showed reduced amplification following NMDA treatment ( Figure S3E ). Thus, activity-induced DSBs are not site-specific but rather occur broadly within the Fos promoter. Taken together, our results indicate that neuronal activityinduced DSBs occur within the promoters of early-response genes and that these DSBs could result from the activities of Topo IIb.
Genome-wide Topo IIb Cleavage Patterns Coincide with Sites of Activity-Induced DNA DSBs To further examine the connections between Topo IIb and activity-induced DSBs, we performed Topo IIb ChIP-seq under basal conditions and following neuronal activity. An analysis of Topo IIb signals within various genomic regions suggested that under basal conditions, Topo IIb binding is enriched primarily at and upstream of the TSS of actively transcribed genes, as well as at enhancer elements, but not at heterochromatin or polycomb repressed regions ( Figure 4A and Table S4 ). A comparison with existing datasets of various factors that bind activity-regulated genes (Kim et al., 2010) revealed that Topo IIb binding is enriched at SRF and CREB binding sites, as well as CBP binding sites within promoters and enhancers ( Figures 4B and 4C ). These results further indicate that Topo IIb binding patterns overlap with regulators of neuronal activity-induced gene expression.
Interestingly, NMDA caused a substantial increase in genomewide Topo IIb binding. Whereas 430 Topo IIb peaks were identified under basal conditions, 2,416 peaks were detected within 20 min of the initial NMDA treatment (Table S4 ). This nearly 5-fold increase in Topo IIb signals was largely proportionally distributed within the same chromatin regions that showed Topo IIb binding under basal conditions ( Figure 4A and Table  S4 ). NMDA treatment also caused an enrichment of Topo IIb signals at SRF, CREB, and CBP binding sites ( Figures 4B and 4C ). These features also extend to the promoters of early-response genes, such as Fos and Npas4, where an increase in Topo IIb signals were clearly detected following neuronal activity ( Figure 4D ). Importantly, Topo IIb signals under both basal and NMDAtreated conditions were found immediately adjoining gH2AX-enriched regions in NMDA-treated samples ( Figure 4D ). These results further suggest that Topo IIb binding patterns are consistent with their role in activity-dependent DNA DSB formation.
To further understand whether Topo IIb-mediated DNA cleavage could underlie the selective pattern of DSB formation in response to neuronal activity, we performed gH2AX ChIP-seq after treatment of cultured primary neurons with etoposide. Similar to results with NMDA treatment, gH2AX signals after etoposide treatment were enriched primarily within gene bodies compared to intergenic regions ( Figure 4E ). Furthermore, aggregate plots revealed that etoposide-induced and NMDA-induced gH2AX signals display a strikingly similar distribution pattern at the sites of activity-induced DSBs ( Figures 4F and S4A) , and this similarity is further emphasized from the comparison of NMDA and etoposide-induced gH2AX signals at individual genes ( Figure S4B ). These data suggest that Topo IIb-mediated DNA cleavage could underlie activity-induced DSB formation in neurons. Figure 2A .
(Right) Disposition of differential gH2AX signals within these annotated genomic regions following etoposide treatment.
(F) Aggregate plots of input-normalized gH2AX signals at the 20 loci that show increased gH2AX intensity following NMDA treatment were generated for NMDAtreated (orange), etoposide-treated (blue) and control (gray) conditions. Graph on the left shows the distribution within a 2 kb window of the transcription start site (TSS), whereas the graph on the right denotes the distribution near the transcription termination site (TTS). Plots were generated using annotatePeaks.pl command of HOMER software and custom R scripts.
Activity-Induced DNA DSBs Occur within CTCF-Generated Topological Domains
We sought to understand the properties that could underlie the positional specificity of activity-induced DSBs. We found that promoters that incur activity-induced DSBs already contain RNAPII pre-bound at the TSS, as well as a chromatin environment that is highly permissive for gene expression even under basal conditions ( Figures S5A and S5B) . However, pre-incubation of cultured neurons with DRB (5,6-Dichloro-1-b-D-ribofuranosylbenzimidazole), an inhibitor of RNAPII elongation (Yankulov et al., 1995) , prior to their treatment with NMDA had no effect on activity-induced DSB formation ( Figure S5C ), indicating that DSBs are not likely formed as a by-product of torsional stress generated during transcription elongation. Importantly, we noted that although NMDA causes a 5-fold increase in the number of Topo IIb peaks, activity-induced DSBs occur at loci that already contain Topo IIb bound under basal conditions and not at sites of nascent Topo IIb peaks following NMDA treatment ( Figure 5A ). We next performed motif scans at Topo IIb binding sites under basal conditions. Interestingly, these studies revealed that the CTCF transcription factor binding site motif (CTCF_1; http:// www.broadinstitute.org/$pouyak/motifs-table/) is the most highly enriched at Topo IIb binding sites. Under basal conditions, a 37-fold enrichment for this motif at Topo IIb binding sites was detected relative to a shuffled control version of this binding site found at a similar number of places in the genome (p value = 1 3 10
À70
). Similarly, a 31-fold enrichment of the CTCF motif at Topo IIb peaks was observed under NMDA-treated conditions (p value < < 1 3 10 À100 ). In fact, in both cases, Topo IIb disposition at these sites was tightly confined to the CTCF motif itself (Figure 5B) . CTCF is an architectural protein that creates topological boundaries through chromatin looping and thereby governs interactions between various regulatory regions, such as promoters and enhancers (Ong and Corces, 2014 Figures 5C and 5D ). Furthermore, immunoprecipitated Topo IIb under basal conditions was able to co-precipitate CTCF, and this interaction was markedly stimulated following NMDA treatment ( Figure S5D ).
To determine whether the association between Topo IIb and CTCF is relevant to activity-induced DSBs, we again utilized the publicly available CTCF ChIP-seq datasets and examined the disposition of CTCF relative to gH2AX signals at the sites of activity-dependent DNA DSBs. Our analysis revealed that the probability of finding a CTCF peak within 2 kb of the boundary of gH2AX regions was significantly greater than the probability of finding permutated random sites in the mappable regions throughout the genome (p < 0.0001). Furthermore, CTCF peaks lie significantly closer to the TSS of genes that incur DSBs following NMDA treatment compared to other genes (Figure S5E ). Aggregate plots of CTCF and gH2AX distribution at sites of activity-induced DSBs further revealed that CTCF peaks tightly envelop gH2AX regions within these loci ( Figure 5E ). Similar results were also observed with gH2AX signals generated after etoposide treatment of neurons ( Figure 5F ; p < 0.0001). These results suggest that CTCF-mediated topological structures at the promoters of early-response genes could stimulate the nucleation of Topo IIb.
Topo IIb-Mediated DNA DSBs Facilitate the Expression of Early-Response Genes Because DSB formation within the promoters of early-response gene correlates with their expression, we tested whether DSBs have an effect on the expression of these genes. To begin, we obtained luciferase reporter constructs that were under the control of either the Fos or the Npas4 regulatory regions, and utilized the CRISPR-Cas9 system to generate targeted DSBs within the promoters of Fos and Npas4 (Ran et al., 2013) (Figure 6A ). Transfection of matching luciferase reporter and Cas9 constructs in HEK293T cells caused a marked increase in luciferase expression in both cases compared to controls in which Cas9 was targeted to cleave the Bdnf promoter ( Figure 6B ). An upregulation of endogenous Fos and Npas4 was also detected when cultured primary neurons were infected with lentiviral vectors carrying Cas9 and the appropriate sgRNAs ( Figure 6C ). These results suggest that the formation of DSBs within the promoters of early-response genes stimulates their expression.
To further understand how the presence of activity-induced DSBs affects early-response gene expression, we assessed DNA repair kinetics of activity-induced DSBs. Because DSB formation within the Fos promoter precludes the amplification of this region in PCR assays ( Figure 3F ), the recovery of amplification was used to indicate successful repair at this locus. Topo IIb ChIP-qPCR at various times after NMDA treatment of cultured primary neurons indicated a significant reduction in PCR amplification of the Fos promoter region at 30 min after the initial NMDA stimulus ( Figure 6D ). However, PCR amplification was restored by 2 hr after NMDA stimulation ( Figure 6D ). Similar results were also observed in PCR assays with genomic DNA directly isolated from cultured primary neurons following NMDA treatment ( Figure S6A ). These results suggest that activity-induced DSBs are repaired within 2 hr of the initial stimulus. Interestingly, Fos, Npas4, and Egr1 mRNA levels after NMDA treatment followed similar dynamics, with transcript levels being markedly upregulated at 30 min after the initial stimulus, but retuning to basal levels by 2 hr after stimulation ( Figure 6E) . Thus, the expression patterns of early-response genes correlate well with the formation and repair of activity-induced DSBs.
We next tested the effects of perturbing DSB repair on the expression of early-response genes by pre-incubating neurons with a specific inhibitor of DNA-PK (NU7026), which is an essential component of DSB repair through nonhomologous end joining (NHEJ) (Veuger et al., 2003) . Pre-incubation with NU7026 prevented the PCR amplification of the Fos promoter regions even after recovery for 2 hr following NMDA treatment, indicating that the repair of activity-induced DSBs is dependent on NHEJ (Figure S6A ). Like before ( Figure 6E) , Fos, Npas4, and Egr1 expression was markedly upregulated upon stimulation and returned to baseline levels by 2 hr post-stimulation in untreated controls. Incubation with NU7026 had no effect on either the basal expression of early-response genes or on their peak induction levels poststimulation (data not shown). However, early-response genes in NU7026-treated samples were delayed in returning to basal levels and were upregulated at 2 hr post-stimulation relative to untreated (legend continued on next page) controls ( Figure 6F ), although the expression of these genes at 2 hr was still lower than their peak induction levels at 30 min post-stimulation (data not shown). These results suggest that the repair of activity-induced DSBs can affect the dynamics of early-response gene expression.
To clarify the role of Topo IIb in activity-induced DSB formation and early-response gene expression, we infected cultured primary neurons with lentiviral vectors carrying shRNAs against Top2b. qRT-PCR experiments performed one week after the lentiviral infections using two distinct shRNAs revealed that both shRNAs were able to knockdown Top2b expression by at least 50% ( Figure S6B ). To examine the effects of Top2b knockdown on DSB formation, we assessed gH2AX enrichment within the exons of early-response genes after NMDA treatment using ChIP-qPCR. Whereas NMDA treatment caused a robust increase in gH2AX levels in the exons of Fos, Npas4, and Egr1 in neurons infected with a scrambled shRNA, this increase was attenuated in neurons infected with Top2b shRNAs ( Figure 6G ). In addition to this, qRT-PCR experiments following NMDA treatment of cultured primary neurons revealed that whereas neurons infected with scrambled shRNA showed a significant induction of Fos and Npas4 transcripts following activity stimulation, the induction of these genes was severely attenuated in neurons infected with Top2b shRNAs ( Figure 6H ). In contrast to Fos and Npas4, the expression of another early-response gene, Arc, which does not incur activity-induced DNA DSBs, was not affected by Top2b knockdown ( Figure S6C ). These results suggest that Topo IIb is essential for activity-induced DSB formation, as well as for the expression of genes that incur activity-induced DSBs.
To evaluate how the loss of Topo IIb affects synaptic functions, we stereotactically injected lentiviral vectors carrying Top2b shRNAs into the CA1 region of the mouse hippocampus. Four weeks after viral injections, we performed extracellular recordings in acute hippocampal slices. As assessment of basal synaptic transmission revealed no significant differences between control slices infected with a scrambled shRNA and slices infected with Top2b shRNAs ( Figure S6D ). However, theta-burst stimulation (TBS)-induced LTP from Schaffer collateral-CA1 synapses was severely impaired in slices infected with Top2b shRNAs ( Figure 6I ). While the slices transduced with scrambled shRNA exhibited 200% fEPSP over baseline, shRNA#1 transduced slices showed 130% and shRNA#2 transduced slices showed 150% fEPSP over baseline over the time course of 60 min following theta-burst stimulation ( Figure 6I ). These results are consistent with a role for Topo IIb in the expression of earlyresponse genes and maintaining synaptic function.
To further understand the connections between activityinduced DSBs, Topo IIb, and early-response gene expression, we performed RNA-seq after NMDA treatment of cultured primary neurons (Table S5 ). Analysis of differentially expressed genes after NMDA treatment revealed that only the early-response genes, Fos, Npas4, FosB, and Egr1, show elevated gH2AX signals. Furthermore, only early-response genes were upregulated by both etoposide and NMDA treatments ( Figures 1B and 1D , and Tables S1 and S5). These results suggest that activity-dependent DSB formation selectively promotes the expression of earlyresponse genes. Finally, we tested whether DSB formation in the context of Topo IIb knockdown could restore the expression of early-response genes. To this end, we infected cultured primary neurons with lentiviral vectors carrying shRNAs against Top2b, together with lentiviral vectors carrying either Cas9 and sgRNAs against the Fos promoter (Cas9-Fos/CRISPR) or Cas9 and sgRNAs against a different region (Cas9-control/Control). We then treated neurons with NMDA and compared Fos levels under these conditions. Consistent with our earlier observations (Figure 6C ), neurons infected with both Cas9-Fos and scrambled shRNA were able to induce Fos under basal conditions ( Figure 6J ). Likewise, neurons infected with Cas9-control and Top2b shRNA showed reduced Fos expression following NMDA treatment (Figure 6J) . In contrast, neurons infected with a combination of Cas9-Fos and Top2b shRNA were able to successfully upregulate Fos expression following NMDA treatment ( Figure 6J ), indicating that DSB formation can restore the expression of early-response genes in the absence of Topo IIb. Taken together, our results suggest that Topo IIb-mediated DSBs facilitate the expression of early-response genes in response to neuronal activity.
DISCUSSION
DSBs Facilitate the Expression of Early-Response Genes
The promoters of early-response genes already display the major hallmarks of transcriptionally active genes under basal conditions, including RNAPII bound at the TSS (Kim et al., 2010) . Moreover, neuronal activity only minimally impacts the profiles of histone methylation and transcription factor binding at these promoters. These observations raise important questions about how the expression of early-response genes is curtailed under basal conditions and how neuronal stimulation causes these genes to be expressed so instantly.
Our results provide three lines of evidence that suggest that DSB formation could help override the impediments to earlyresponse gene expression: (1) DSB formation in the promoters of early-response genes using either etoposide ( Figures 1D,  4F , and S4B) or CRISPR-Cas9 ( Figures 6B and 6C ) is sufficient to induce the expression of early-response genes even in the absence of neuronal activity, (2) inhibition of DSB repair results in persistent expression of early-response genes ( Figure 6F ), and (3) Topo IIb knockdown precludes the expression of earlyresponse genes following neuronal activity; however, gene expression can be restored under these conditions by the generation of targeted DSBs ( Figure 6J ).
(D) A similar analysis to (C) was conducted using another publicly available CTCF ChIP-seq dataset from mouse neural progenitors (Phillips-Cremins et al., 2013) . Three distinct sgRNAs were used for each locus (#1-#3). Luciferase expression was measured 16 hr after transfection. As a control, luciferase reporter constructs in each case were transfected with Cas9 and sgRNAs directed to the Bdnf promoter (n = 3, *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA) (C) Cultured primary neurons were infected with lentiviral vectors carrying Cas9 and sgRNAs directed to either the Fos or the Npas4 promoter. RNA was extracted 8 days post-infection and the expression of Fos and Npas4 was determined relative to neurons infected with sgRNAs directed to the Bdnf promoter using qRT-PCR (n = 3, **p < 0.01, two-tailed t test).
(D) Cultured primary neurons were treated with NMDA as before and allowed to recover in NMDA-free media. Topo IIb ChIP was then performed at the indicated times and the amplification of the Fos promoter was assessed as in Figure 3A (n = 3, *p < 0.05, two-way ANOVA).
(E) Cultured primary neurons were treated with NMDA as before and allowed to recover in NMDA-free media. RNA was then extracted at the indicated times and the expression of Fos, Npas4, and Egr1 was assessed using qRT-PCR (n = 4, ***p < 0.001, one way-ANOVA).
(F) Cultured primary neurons were incubated with a specific inhibitor of DNA-PK (NU7026) for 1 hr, following which neurons were treated with NMDA and allowed to recover in NMDA-free media. RNA was extracted 2 hr after the initial NMDA treatment (time = 0, x axis), and the levels of Fos, Npas4, and Egr1 was assessed relative to neurons treated with NMDA in the absence of NU7026 using qRT-PCR (n = 4, *p < 0.05, two-tailed t test).
(G) Cultured primary neurons were infected with lentiviral vectors carrying either a scrambled shRNA (control) or one of two distinct shRNAs against Top2b (shRNA#1 or shRNA#2). One week after the infection, neurons were treated with NMDA (50 mM) for 10 min followed by recovery in NMDA-free media for an additional 10 min. Enrichment of gH2AX within exons of Fos, Npas4, and Egr1 was assessed using ChIP. As a control, the Fos promoter region was also probed (n = 3, **p < 0.01, two-way ANOVA).
(legend continued on next page)
Topological Factors Constrain the Expression of Early-Response Genes
The involvement of Topo IIb suggests the existence of topological constraints that could govern the expression of earlyresponse genes. However, the precise nature of these topological constraints is presently unclear. Topo IIb activity upstream of the TSS is generally important for transcription elongation (Teves and Henikoff, 2014) . In fact, Topo IIb is known to bind to the 5 0 ends of actively transcribed neurodevelopmental genes and promote their expression (Lyu et al., 2006; Tiwari et al., 2012) . As mentioned above, the promoters of early-response genes already contain paused RNAPII under basal conditions, and activity-induced DSB formation could be a way to rapidly resolve topological barriers to RNAPII movement. Torsional stress generated during transcription initiation at these promoters could cause Topo IIb recruitment under basal conditions. Notably however, the recruitment of Topo IIb to the promoters of early-response genes under basal conditions does not result in the formation of DSBs, and the potential relaxation of supercoils by Topo IIb under basal conditions by itself is insufficient to induce the expression of early-response genes. Furthermore, blocking transcription elongation does not affect activity-dependent DSB formation ( Figure S5C ). Despite these, the possibility that neuronal activity spawns new transcription-related torsional forces that induce DSB formation by Topo IIb cannot be ruled out.
Separate from transcription-related torsional factors however, the TSS of genes that incur activity-dependent DSBs are characterized by their close proximity to CTCF binding sites compared to the TSS of other genes ( Figure S5E ), and Topo IIb binding is preferentially enriched at CTCF binding sites ( Figure 5 ). We believe these observations provide insights into a distinct topological constraint to early-response gene expression. CTCFmediated chromatin loops create topological barriers that govern the interactions between distinct regulatory regions, such as promoters and enhancers (Ong and Corces, 2014) . Enhancer-promoter interactions are known to be essential for the expression of early-response genes. Enhancers of earlyresponse genes are also pre-bound by SRF and CREB and recruit RNAPII and CBP following neuronal activity, and several studies indicate that RNAPII recruited to enhancer loci might be transferred to promoters following activity stimulation (Kim et al., 2010; Koch et al., 2008) . Within this context, the formation of Topo IIb-mediated DSBs at CTCF binding sites in an activitydependent manner constitutes an attractive model that would rapidly dissolve topological constraints to enhancer-promoter interactions and instantly stimulate the expression of earlyresponse genes.
Implications of Activity-Dependent DSB Formation in Neurodegeneration Because activity-dependent DSBs form in the regulatory regions of genes that govern crucial neuronal functions, the dynamics of their formation and repair is likely to have important physiological and pathological implications. Interestingly, androgen signaling was previously shown to induce Topo IIb-mediated DSBs that results in oncogenic rearrangements observed in human prostate cancer (Haffner et al., 2010) . These observations raise the intriguing question of whether unrepaired or erroneously repaired DSBs produced in response to neuronal activity could contribute to the development of neurological disorders. Elevated DNA DSBs have been reported in a variety of congenital and age-related neurological disorders (Madabhushi et al., 2014; McKinnon, 2013) . However, the relevant sources that lead to DSB accumulation in these disorders remain unknown. Interestingly, it was recently reported that amyloid b accumulation, which is a hallmark of Alzheimer's disease, can exacerbate the accumulation of DSBs that are produced during normal physiological neuronal activities in mice (Suberbielle et al., 2013) . It would be interesting to test whether elevated DSBs in this mouse model, as well as in other mouse models and postmortem brains of patients with neurodegenerative disorders, overlap with the sites of activity-induced DNA DSBs.
The enrichment of TDP2 at the promoters of early-response genes ( Figure S3B ) suggests that activity-induced DSBs are likely repaired error-free despite the utilization of the NHEJ pathway ( Figure 6F ). In cells lacking TDP2, Topo IIb-mediated DSBs are repaired using alternative mechanisms of end joining that are dependent on ATM (Á lvarez-Quiló n et al., 2014). However, such end-processing steps could be mutagenic. It was recently reported that individuals carrying mutations in TDP2 manifest with intellectual disability, epilepsy, and ataxia, and that the loss of TDP2 in cultured human cells and postmitotic neurons caused hypersensitivity to Topo IIb-mediated DSBs (Gó mez-Herreros et al., 2014 ). An assessment of TDP2 activity in various neurodegenerative mouse models that are characterized by elevated levels of DNA DSBs would likely provide further insights in this direction.
EXPERIMENTAL PROCEDURES Neuronal Cultures and Treatments
Dissociated cortical neurons from E16 Swiss-Webster mice were plated at a density of 12.5 million cells/plate in10 cm plates. The plates were coated beforehand by incubation with poly-D-lysine (0.5 mg/ml) and laminin (0.005 mg/ml) for 1 hr at 37 C, followed by washing twice with dH 2 O. Neurons were maintained in neurobasal media (GIBCO) and supplemented with L-glutamine, penicillin/streptomycin, and B27.
(H) Cultured primary neurons were infected with Top2b shRNAs and treated with NMDA as in (G). RNA was then extracted and the levels of Fos and Npas4 were probed using qRT-PCR (n = 4, **p < 0.01, one-way ANOVA).
(I) Scrambled and Top2b shRNAs were stereotactically injected into the hippocampus of two-month old C57BL/6 mice. Four weeks after the injections, acute hippocampal slices were prepared and LTP was induced by 33 TBS at the Schaffer collateral-CA1 synapses. Sample traces represent fEPSPs 1 min before (gray) and 1 hr after (black) TBS. Scale bars, 1 mV and 20 ms (5-6 slices per animal, 3 animals per group, *p < 0.05, one-way ANOVA).
(J) Cultured primary neurons were infected with a combination of lentiviral vectors carrying Cas9 and sgRNAs directed to the Fos promoter (CRISPR) together with Top2b shRNAs. Controls represent neurons infected with Cas9 and sgRNAs directed to the Bdnf promoter together with scrambled shRNAs (control). One week after the lentiviral infections, neurons were treated with NMDA (50 mM) for 10 min followed by recovery in NMDA-free media for 10 min. RNA was then extracted and Fos expression was assessed using qRT-PCR (n = 3, *p < 0.05 one-way ANOVA).
Neuronal activity was induced by treatment with indicated concentrations of potassium chloride (KCl), bicucullin (Bic), and N-methyl-D-aspartate (NMDA). For most experiments, cultured primary neurons were treated with 50 mM NMDA for 10 min followed by recovery in NMDA-free conditional media for an additional 10 min. Etoposide (Sigma) was at 5 mM, Olaparib (PARPi) (Selleck) at 10 mM, Ncs was at 1 mM, and NU7026 (Calbiochem) was at 10 mM.
DNA Cleavage Assays
Topo IIb-mediated DNA cleavage assays were essentially carried out as described (Nitiss et al., 2012) . Briefly, reaction mixtures (20 ml) containing 10 mM Tris (pH 8), 50 mM NaCl, 50 mM KCl, 5 mM MgCl 2 , 0.1 mM EDTA, 15 mg/ml BSA, and 10 nM supercoiled plasmids (Fos-luc, Npas4-luc, DFos-luc, and DNpas4-luc) were incubated with 8 units of recombinant Topo IIb-His (LAE Biotech). Where indicated, etoposide was at 0.2 mM. Reactions were incubated at 30 C for 10 min. DNA cleavage products were trapped by addition of 2 ml of 10% SDS. Samples were then treated with 1 ml of 250 mM EDTA and 2 ml of 1 mg/ml proteinase K and incubated at 37 C for 45 min.
Samples were then loaded onto 1% TAE agarose gels and electrophoresed at 5 V/cm for 4 hr. Gels were stained with 1 mg/ml ethidium bromide for 30 min and visualized.
In Vivo Complex of Enzyme Assay ICE assays were performed essentially as described (Nitiss et al., 2012) . Cultured primary neurons were lysed with 1% sarkosyl, and the DNA was sheared using a 1 ml syringe with a 25G/8 gauge needle. Lysates were passed 10 times through the needle. Lysates (2 ml) were then layered atop a 2 ml CsCl solution in 13 3 51 mm polycarbonate centrifuge tubes (Beckman) and spun at 71,000 rpm in an SLA-100.3 rotor (Beckman) for 12 hr at room temperature. Pellets were washed with 70% ethanol and resuspended in TE buffer (pH 7.5). Indicated amounts of DNA were applied to a nitrocellulose membrane using a slot-blot apparatus (Bio-Rad) following manufacturer's instructions. The membranes were then analyzed for Topo IIb using standard western blotting procedures.
ChIP-Seq, RNA-Seq, ChIP-qPCR, Behavioral and Elecrophysiological Paradigms Please refer to Supplementary Information for details of these procedures. A comprehensive list of primers used for these methods can be found in Table S6 .
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